Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$227.63
+0.5%
$203.74
$137.75
$233.60
$53.02B0.522.07 million shs3.03 million shs
Cencora, Inc. stock logo
COR
Cencora
$281.22
-0.1%
$287.49
$244.82
$377.54
$54.76B0.591.45 million shs1.01 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$417.07
+0.1%
$441.47
$396.68
$603.88
$147.53B1.462.34 million shs1.84 million shs
Stryker Corporation stock logo
SYK
Stryker
$310.71
+0.9%
$315.51
$281.00
$404.87
$118.05B0.782.64 million shs1.75 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.49%+7.27%+16.68%+7.60%+40.14%
Cencora, Inc. stock logo
COR
Cencora
-0.13%+0.74%+9.44%-13.60%-3.82%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+0.12%-2.24%-0.96%-12.70%-19.65%
Stryker Corporation stock logo
SYK
Stryker
+0.93%-1.18%+1.29%-10.11%-17.59%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$227.63
+0.5%
$203.74
$137.75
$233.60
$53.02B0.522.07 million shs3.03 million shs
Cencora, Inc. stock logo
COR
Cencora
$281.22
-0.1%
$287.49
$244.82
$377.54
$54.76B0.591.45 million shs1.01 million shs
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$417.07
+0.1%
$441.47
$396.68
$603.88
$147.53B1.462.34 million shs1.84 million shs
Stryker Corporation stock logo
SYK
Stryker
$310.71
+0.9%
$315.51
$281.00
$404.87
$118.05B0.782.64 million shs1.75 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
+0.49%+7.27%+16.68%+7.60%+40.14%
Cencora, Inc. stock logo
COR
Cencora
-0.13%+0.74%+9.44%-13.60%-3.82%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
+0.12%-2.24%-0.96%-12.70%-19.65%
Stryker Corporation stock logo
SYK
Stryker
+0.93%-1.18%+1.29%-10.11%-17.59%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.82
Moderate Buy$246.938.48% Upside
Cencora, Inc. stock logo
COR
Cencora
2.80
Moderate Buy$374.0032.99% Upside
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
2.67
Moderate Buy$573.4237.49% Upside
Stryker Corporation stock logo
SYK
Stryker
2.73
Moderate Buy$395.3327.24% Upside

Current Analyst Ratings Breakdown

Latest SYK, ISRG, CAH, and COR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/12/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
DowngradeStrong-BuyHold
6/12/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price Target$520.00 ➝ $515.00
6/10/2026
Cencora, Inc. stock logo
COR
Cencora
Lower Price TargetOverweight$425.00 ➝ $350.00
6/5/2026
Stryker Corporation stock logo
SYK
Stryker
Lower Price TargetOutperform$410.00 ➝ $407.00
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingOverweight$580.00
6/2/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetSell$440.00 ➝ $366.00
5/27/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Set Price Target$558.00
5/22/2026
Cencora, Inc. stock logo
COR
Cencora
DowngradeBuy (B)Buy (B-)
5/19/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
DowngradeBuy (B+)Buy (B)
5/19/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Reiterated RatingHold (C)
5/18/2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
Lower Price TargetBuy$650.00 ➝ $520.00
(Data available from 6/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$222.58B0.24$11.73 per share19.40($11.04) per share-20.62
Cencora, Inc. stock logo
COR
Cencora
$321.33B0.17$21.60 per share13.02$9.01 per share31.21
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$10.06B14.68$9.29 per share44.90$50.52 per share8.26
Stryker Corporation stock logo
SYK
Stryker
$25.27B4.71$17.04 per share18.23$58.63 per share5.30
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.56B$6.5434.8119.001.240.62%-92.61%4.46%8/11/2026 (Estimated)
Cencora, Inc. stock logo
COR
Cencora
$1.55B$13.0421.5714.281.520.78%135.20%4.20%8/5/2026 (Estimated)
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.86B$8.2550.5542.513.3928.15%15.98%14.07%7/28/2026 (Estimated)
Stryker Corporation stock logo
SYK
Stryker
$3.25B$8.6435.9618.741.9713.20%23.42%11.04%7/30/2026 (Estimated)

Latest SYK, ISRG, CAH, and COR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/6/2026Q2 2026
Cencora, Inc. stock logo
COR
Cencora
$4.82$4.75-$0.07$8.40$81.09 billion$78.36 billion
4/30/2026Q3 2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.79$3.17+$0.38$1.69$62.10 billion$60.94 billion
4/30/2026Q1 2026
Stryker Corporation stock logo
SYK
Stryker
$2.98$2.60-$0.38$1.93$6.34 billion$6.02 billion
4/21/2026Q1 2026
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
$2.08$2.50+$0.42$2.28$2.62 billion$2.77 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.040.90%+1.02%31.19%29 Years
Cencora, Inc. stock logo
COR
Cencora
$2.400.85%+5.79%18.40%15 Years
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/AN/AN/AN/AN/A
Stryker Corporation stock logo
SYK
Stryker
$3.521.13%+7.58%40.74%32 Years

Latest SYK, ISRG, CAH, and COR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2026
Stryker Corporation stock logo
SYK
Stryker
quarterly$0.881.2%6/30/20266/30/20267/31/2026
5/5/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.51581.05%7/1/20267/1/20267/15/2026
5/5/2026
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.600.93%5/15/20265/15/20266/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.91
0.48
Cencora, Inc. stock logo
COR
Cencora
3.40
0.95
0.59
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
N/A
4.61
3.59
Stryker Corporation stock logo
SYK
Stryker
0.62
2.11
1.25

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Cencora, Inc. stock logo
COR
Cencora
97.52%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
83.64%
Stryker Corporation stock logo
SYK
Stryker
77.09%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.12%
Cencora, Inc. stock logo
COR
Cencora
0.38%
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
0.60%
Stryker Corporation stock logo
SYK
Stryker
4.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
57,700234.21 million233.93 millionOptionable
Cencora, Inc. stock logo
COR
Cencora
51,000194.56 million193.82 millionOptionable
Intuitive Surgical, Inc. stock logo
ISRG
Intuitive Surgical
17,021354.16 million352.04 millionOptionable
Stryker Corporation stock logo
SYK
Stryker
56,000383.36 million365.73 millionOptionable

Recent News About These Companies

3 Big Reasons SYK Should Be On Your Watchlist

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cardinal Health stock logo

Cardinal Health NYSE:CAH

$227.63 +1.23 (+0.55%)
Closing price 06/16/2026 03:59 PM Eastern
Extended Trading
$232.34 +4.71 (+2.07%)
As of 04:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cencora stock logo

Cencora NYSE:COR

$281.22 -0.21 (-0.08%)
Closing price 06/16/2026 03:59 PM Eastern
Extended Trading
$278.50 -2.72 (-0.97%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Intuitive Surgical stock logo

Intuitive Surgical NASDAQ:ISRG

$417.07 +0.52 (+0.12%)
Closing price 06/16/2026 04:00 PM Eastern
Extended Trading
$418.51 +1.44 (+0.35%)
As of 05:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Stryker stock logo

Stryker NYSE:SYK

$310.71 +2.77 (+0.90%)
Closing price 06/16/2026 03:59 PM Eastern
Extended Trading
$310.24 -0.47 (-0.15%)
As of 04:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.